Trending Now
When Mites Meet Their Match: Empowering Patients With Targeted Treatment for Demodex Blepharitis | Ophthalmology Times
International Glaucoma Symposium highlights the meeting point of practice and technology | Ophthalmology Times
MRI study links glymphatic system dysfunction to idiopathic intracranial hypertension | Ophthalmology Times
Breaking News
Surgical innovation in dry eye disease: Salivary gland transplant
Next-generation IOLs advance complex cataract care
OCT changes with low-level red light therapy for myopia in children
Alcon presenting at APACRS 2025
Breaking News
Popular Now
MacTel Decoded: Rethinking Conventional Approaches with Novel Neuroprotective Strategies | Ophthalmology Times
Thanks for your interest in this podcast. Please read this important program…
When Mites Meet Their Match: Empowering Patients With Targeted Treatment for Demodex Blepharitis | Ophthalmology Times
Thanks for your interest in this podcast. Please read this important program…
International Glaucoma Symposium highlights the meeting point of practice and technology | Ophthalmology Times
The 2nd International Glaucoma Symposium underscores how AI and advanced imaging are…
MRI study links glymphatic system dysfunction to idiopathic intracranial hypertension | Ophthalmology Times
(Image Credit: AdobeStock/littlewolf1989) A press release from Mass General Brigham, Boston, reported…
Collaborate With Us
Editor Choice
Primary Open Angle Glaucoma (POAG)
A subtype of glaucomas known as primary open angle glaucoma (POAG) is…
Researchers Investigate Impact of Altered Gravity on Eye Health
As the accessibility of space travel grows, so does the urgency to…
What Is Vision Therapy and Who Needs It
Vision therapy is a specialized form of optometric care that utilizes a…
What is Photophobia and How to Manage it
Photophobia, or sensitivity to light, is a common condition characterized by discomfort…
Harrow Starts Triesence Relaunch Strategy
Harrow Pharmaceuticals announced its efforts to relaunch Triesence (triamcinolone acetonide injectable suspension)…
Opus Secures $1.7M Funding from Foundation Fighting Blindness
Opus Genetics, a pioneering gene therapy company focused on inherited retinal diseases,…
FDA Grants Breakthrough and RMAT Status to Aurion’s AURN001
Aurion Biotech has been granted Breakthrough Therapy Designation (BTD) and Regenerative Medicine…
RevOpsis and Kemwell Form Manufacturing Partnership for nAMD
RevOpsis Therapeutics and Kemwell Biopharma have forged a strategic manufacturing partnership aimed…
Oculis’ Licaminlimab Shows Promise in Phase 2B Trial for DED
Oculis Holding announced positive topline results from its phase 2b RELIEF trial,…
Worth Reading
Meeting expectations with evolving technology
Unpacking high-yield ophthalmology tips and clinical pearls, with Nicole Bajic, MD
Possible protective role of cannabis in preventing postoperative proliferative vitreoretinopathy after retinal detachment repair
Next-generation IOLs advance complex cataract care
Subscribe Now
Enter your email address below and subscribe to our newsletter






















